ATE277921T1 - Selektiv auf den cb2-rezeptor wirkende cannabinoide - Google Patents

Selektiv auf den cb2-rezeptor wirkende cannabinoide

Info

Publication number
ATE277921T1
ATE277921T1 AT99921676T AT99921676T ATE277921T1 AT E277921 T1 ATE277921 T1 AT E277921T1 AT 99921676 T AT99921676 T AT 99921676T AT 99921676 T AT99921676 T AT 99921676T AT E277921 T1 ATE277921 T1 AT E277921T1
Authority
AT
Austria
Prior art keywords
receptor
cannabinoids
cannabinoid
novel
ring
Prior art date
Application number
AT99921676T
Other languages
English (en)
Inventor
Alexandros Makriyannis
Atmaram Khanolkar
Dai Lu
Original Assignee
Univ Connecticut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Connecticut filed Critical Univ Connecticut
Application granted granted Critical
Publication of ATE277921T1 publication Critical patent/ATE277921T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78Ring systems having three or more relevant rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT99921676T 1998-05-04 1999-05-04 Selektiv auf den cb2-rezeptor wirkende cannabinoide ATE277921T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8412998P 1998-05-04 1998-05-04
PCT/US1999/009806 WO1999057107A2 (en) 1998-05-04 1999-05-04 Cannabinoids selective for the cb2 receptor

Publications (1)

Publication Number Publication Date
ATE277921T1 true ATE277921T1 (de) 2004-10-15

Family

ID=22183058

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99921676T ATE277921T1 (de) 1998-05-04 1999-05-04 Selektiv auf den cb2-rezeptor wirkende cannabinoide

Country Status (7)

Country Link
US (1) US6166066A (de)
EP (1) EP1076653B1 (de)
AT (1) ATE277921T1 (de)
CA (1) CA2340444A1 (de)
DE (1) DE69920683T2 (de)
ES (1) ES2224658T3 (de)
WO (1) WO1999057107A2 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE277921T1 (de) * 1998-05-04 2004-10-15 Univ Connecticut Selektiv auf den cb2-rezeptor wirkende cannabinoide
CA2340445A1 (en) * 1998-05-04 1999-11-11 The University Of Connecticut Novel analgesic and immunomodulatory cannabinoids
US7589220B2 (en) 1998-06-09 2009-09-15 University Of Connecticut Inhibitors of the anandamide transporter
US7897598B2 (en) 1998-06-09 2011-03-01 Alexandros Makriyannis Inhibitors of the anandamide transporter
US7276613B1 (en) 1998-11-24 2007-10-02 University Of Connecticut Retro-anandamides, high affinity and stability cannabinoid receptor ligands
US7161016B1 (en) 1998-11-24 2007-01-09 University Of Connecticut Cannabimimetic lipid amides as useful medications
US20070179135A1 (en) * 2006-01-05 2007-08-02 Travis Craig R Cannabinoid derivatives
US6900236B1 (en) 1999-10-18 2005-05-31 University Of Connecticut Cannabimimetic indole derivatives
US7741365B2 (en) * 1999-10-18 2010-06-22 University Of Connecticut Peripheral cannabinoid receptor (CB2) selective ligands
US7119108B1 (en) 1999-10-18 2006-10-10 University Of Connecticut Pyrazole derivatives as cannabinoid receptor antagonists
US8084467B2 (en) * 1999-10-18 2011-12-27 University Of Connecticut Pyrazole derivatives as cannabinoid receptor antagonists
US6943266B1 (en) * 1999-10-18 2005-09-13 University Of Connecticut Bicyclic cannabinoid agonists for the cannabinoid receptor
CA2387764A1 (en) 1999-10-18 2001-04-26 University Of Connecticut Peripheral cannabinoid receptor (cb2) selective ligands
US7393842B2 (en) * 2001-08-31 2008-07-01 University Of Connecticut Pyrazole analogs acting on cannabinoid receptors
DE60125541T2 (de) * 2000-06-22 2007-10-11 Pharmos Corp. Neue nicht psychotropische cannabinoide
US7235584B2 (en) * 2000-06-22 2007-06-26 Pharmos Corporation Non-psychotropic cannabinoids
EP1361876A4 (de) * 2001-01-26 2004-03-31 Univ Connecticut Neue cannabimimetische liganden
DE60237431D1 (de) 2001-01-29 2010-10-07 Univ Connecticut Rezeptor-selektive cannabimimetische aminoalkylindole
JP4312594B2 (ja) * 2001-07-13 2009-08-12 ユニバーシティ オブ コネチカット 新規な二環式及び三環式カンナビノイド
US7666867B2 (en) * 2001-10-26 2010-02-23 University Of Connecticut Heteroindanes: a new class of potent cannabimimetic ligands
EP1461027A4 (de) * 2001-12-07 2005-09-07 Univ Virginia Commonwealth Behandlung von neoplasie
WO2003075917A1 (en) 2002-03-08 2003-09-18 Signal Pharmaceuticals, Inc. Combination therapy for treating, preventing or managing proliferative disorders and cancers
DE60320784D1 (de) * 2002-06-06 2008-06-19 Yissum Res Dev Co Stände zur modulierung des knochenwachstums
AU2003265663A1 (en) 2002-08-23 2004-03-11 University Of Connecticut Keto cannabinoids with therapeutic indications
IL160420A0 (en) * 2004-02-16 2004-07-25 Yissum Res Dev Co Treating or preventing diabetes with cannabidiol
EP1758566A2 (de) * 2004-06-22 2007-03-07 Pharmos Limited Verwendung von agonisten des cb-2-rezeptors zur behandlung von chorea huntington
US7781650B2 (en) * 2007-04-30 2010-08-24 Monsanto Technology Llc Plants and seeds of corn variety CV202909
US9575319B2 (en) 2014-03-10 2017-02-21 Ion Virtual Technology Corporation Method and system for reducing motion blur when experiencing virtual or augmented reality environments
US10239808B1 (en) 2016-12-07 2019-03-26 Canopy Holdings, LLC Cannabis extracts
EP3509638B1 (de) 2017-06-20 2022-01-12 Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Cannabidiolsäureesterzusammensetzungen und verwendungen davon
CA3089994A1 (en) 2018-01-31 2019-08-08 Canopy Holdings, LLC Hemp powder
WO2020077153A1 (en) 2018-10-10 2020-04-16 Canopy Holdings, LLC Synthesis of cannabigerol
US12403114B2 (en) 2019-03-12 2025-09-02 Epm (Ip), Inc. Cannabinoid acid ester compositions and uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3915996A (en) * 1972-10-16 1975-10-28 Abbott Lab Process for making benzopyrans
US3886184A (en) * 1973-08-03 1975-05-27 Lilly Co Eli Aminodibenzo(b,d)pyrans
US4833073A (en) * 1987-01-27 1989-05-23 Hoffmann-La Roche Inc. Immunoassay for tetrahydrocannabinol metabolites
US5440052A (en) * 1993-08-06 1995-08-08 University Of Connecticut Compositions useful as a cannabinoid receptor probe
FR2735774B1 (fr) * 1995-06-21 1997-09-12 Sanofi Sa Utilisation de composes agonistes du recepteur cb2 humain pour la preparation de medicaments immunomodulateurs, nouveaux composes agonistes du recepteur cb2 et les compositions pharmaceutiques les contenant
US5688825A (en) * 1996-05-31 1997-11-18 University Of Connecticut Anandamide amidase inhibitors as analgesic agents
ATE277921T1 (de) * 1998-05-04 2004-10-15 Univ Connecticut Selektiv auf den cb2-rezeptor wirkende cannabinoide
CA2340445A1 (en) * 1998-05-04 1999-11-11 The University Of Connecticut Novel analgesic and immunomodulatory cannabinoids

Also Published As

Publication number Publication date
WO1999057107A2 (en) 1999-11-11
EP1076653B1 (de) 2004-09-29
US6166066A (en) 2000-12-26
CA2340444A1 (en) 1999-11-11
WO1999057107A3 (en) 2000-02-03
DE69920683T2 (de) 2005-04-07
ES2224658T3 (es) 2005-03-01
EP1076653A2 (de) 2001-02-21
DE69920683D1 (de) 2004-11-04

Similar Documents

Publication Publication Date Title
ATE277921T1 (de) Selektiv auf den cb2-rezeptor wirkende cannabinoide
ATE371670T1 (de) Reinigung von neurotrophinen
ES2107518T3 (es) Polimeros estabilizados con heteroatomos en la cadena principal.
EA199700156A1 (ru) Производные индола как антагонисты рецептора 5-нт
TR200000782T2 (tr) Resorsinol türevleri.
ATE254456T1 (de) Cannabinoid-rezeptor-antagonisten
AR010062A1 (es) Nuevos benzamidaldehidos y su utilizacion
TR199900501T2 (xx) Benzamin t�revleri ve bunlar�n ila� olarak kullan�m�.
NO891309L (no) Fremgangsmaate for separasjon av hydrobehandlede avloepsstroemmer.
ATE289810T1 (de) Ecteinascidinderivate
ES8505539A1 (es) Procedimiento para la obtencion de derivados de alcohol bencilico con propiedades sebosupresoras
ES2171911T3 (es) Poliaminas conformacionalmente restringidas y su uso como agentes antineoplasicos.
EA199700242A1 (ru) Индазолкарбоксамиды, способ их получения, фармкомпозиция и способ ингибирования 5-нтрецептора
FI974434A0 (fi) Trisyklisiä 5,6-dihydro-9H-pyratsolo(3,4-c)-1,2,4,-triatsolo(4,3-alfapidiinejä
DE69521883D1 (de) Aromatische 2-amino-imidazolderivate als alpha 2a-adrenoceptor agonisten
DK0983275T3 (da) Nye triptolidderivater, der er nyttige til behandling af autoimmune sygdomme
FI964045L (fi) CCK:ta tai gastriinia säätelevä 5-heterosykli-1,5-bentsodiatsepiinejä
DE59607649D1 (de) Di-1,3-Dioxan-Derivate als Flüssigkristalle
TR199801612T2 (xx) Benzotiofen, benzotiofen i�eren form�ller ve y�ntemler.
DE69707098D1 (de) Substituierte tetralylmethylenoxindol-analoga als tyrosinkinase-inhibitoren
ES2140672T3 (es) Compuestos biciclicos sustituidos, fusionados y puentes utilizados como agentes terapeuticos.
DE69703788D1 (de) Hochmolekulares Dibenzoylresorcinol als UV Absorber
ES2167725T3 (es) Procedimiento para la coloracion de material organico de alto peso molecular, y pigmentos policiclicos.
EA199800029A1 (ru) СПОСОБ ПОЛУЧЕНИЯ БЕНЗО[b]ТИОФЕНОВ
DK0946538T3 (da) Indan- eller dihydroindole derivater

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties